Stock Analysis

TegoScience Inc.'s (KOSDAQ:191420) market cap dropped ₩29b last week; Retail investors bore the brunt

KOSDAQ:A191420
Source: Shutterstock

Key Insights

  • Significant control over TegoScience by retail investors implies that the general public has more power to influence management and governance-related decisions
  • A total of 7 investors have a majority stake in the company with 43% ownership
  • Insider ownership in TegoScience is 42%

Every investor in TegoScience Inc. (KOSDAQ:191420) should be aware of the most powerful shareholder groups. We can see that retail investors own the lion's share in the company with 57% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

Following a 17% decrease in the stock price last week, retail investors suffered the most losses, but insiders who own 42% stock also took a hit.

Let's delve deeper into each type of owner of TegoScience, beginning with the chart below.

Check out our latest analysis for TegoScience

ownership-breakdown
KOSDAQ:A191420 Ownership Breakdown May 22nd 2024

What Does The Lack Of Institutional Ownership Tell Us About TegoScience?

We don't tend to see institutional investors holding stock of companies that are very risky, thinly traded, or very small. Though we do sometimes see large companies without institutions on the register, it's not particularly common.

There are many reasons why a company might not have any institutions on the share registry. It may be hard for institutions to buy large amounts of shares, if liquidity (the amount of shares traded each day) is low. If the company has not needed to raise capital, institutions might lack the opportunity to build a position. Alternatively, there might be something about the company that has kept institutional investors away. TegoScience might not have the sort of past performance institutions are looking for, or perhaps they simply have not studied the business closely.

earnings-and-revenue-growth
KOSDAQ:A191420 Earnings and Revenue Growth May 22nd 2024

Hedge funds don't have many shares in TegoScience. Looking at our data, we can see that the largest shareholder is the CEO Saewha Jeon with 38% of shares outstanding. In comparison, the second and third largest shareholders hold about 4.8% and 0.2% of the stock. Interestingly, the second-largest shareholder, Jaewook Jeon is also Top Key Executive, again, pointing towards strong insider ownership amongst the company's top shareholders.

On studying our ownership data, we found that 7 of the top shareholders collectively own less than 50% of the share register, implying that no single individual has a majority interest.

While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of TegoScience

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

It seems insiders own a significant proportion of TegoScience Inc.. Insiders have a ₩60b stake in this ₩142b business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public -- including retail investors -- own 57% of TegoScience. This level of ownership gives investors from the wider public some power to sway key policy decisions such as board composition, executive compensation, and the dividend payout ratio.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand TegoScience better, we need to consider many other factors. For instance, we've identified 2 warning signs for TegoScience (1 doesn't sit too well with us) that you should be aware of.

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Valuation is complex, but we're helping make it simple.

Find out whether TegoScience is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.